Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Grasim Industries shares surge 4% after robust Q4 profit, up 28% YoY
Grasim Industries shares saw a significant jump after the company announced robust fourth-quarter earnings and record annual revenue. Growth was broad-based across its paints, chemicals, fibres, cement, and financial services businesses. Consolidated net profit rose 28% year-on-year for Q4FY26. Full-year profit increased 33% to Rs 10,300 crore. Annual revenue hit an all-time high of Rs 1,75,430 crore.
Stocks to Watch for May 21: Aditya Birla Capital, Dr Reddy's Lab, Jubilant Food, Bosch India and more
From Dr Reddy's Laboratories announcing the launch of its oral semaglutide biosimilar in India under the brand name Obeda to Whirlpool of India Ltd reporting a 32.7% year-on-year decline in net profit Q4, here are some stocks to track ahead of Thursday trading session.
Aditya Birla Grp to invest Rs 3,080 cr in fin services arm, IFC to pump Rs 920 cr
Aditya Birla Capital is raising Rs 4,000 crore for future growth. The Aditya Birla Group will invest Rs 3,080 crore and IFC will invest Rs 980 crore. This capital infusion will fund growth objectives, including lending and investments. The company aims to expand access to financing for entrepreneurs and businesses. This move supports India's economic transformation and financial inclusion.
Aditya Birla Capital Approves Rs 4,000-Cr Share Issuance; Promoter Grasim Leads Infusion
Aditya Birla Capital plans to raise Rs 2,880 crore from promoter Grasim Industries.
Aditya Birla Capital raises ₹4,000 crore to fund growth, confirms CNBC-TV18 Newsbreak
The company said the proceeds from the issue will be used for growth objectives, augmentation of the capital base, funding requirements for the lending business and general corporate purposes, including investments in subsidiaries, joint ventures and associates.
Eris Life Q4 Results: Stock gains 12% as Domestic Branded Formulations leads growth
The management of Eris Lifesciences said the phased rollout of the semaglutide portfolio, including pen-based products and obesity-focused SKUs, is expected to support growth momentum going ahead.
Hindalco share price jumps 4% after Novelis posts Q4 earnings 2026; check results date for the Aditya Birla Group stock
Hindalco Industries shares rose 4% to ₹1,089.60 after Novelis reported a quarterly net loss of $84 million. Despite fire-related impacts, quarterly net sales increased 4% to $4.8 billion, driven by higher aluminium prices.
Sensex Rejig: Trent likely exclusion; Could be replaced by either of these two names
Two names remain the key contenders to replace Trent in the Sensex as part of the rejig. One is Aditya Birla Group's Hindalco Industries, and the other is Shriram Finance.
Vodafone Idea’s survival has certainty, but shareholders’ patience may be tested
Vodafone Idea reduced its loss before tax by 13% to ₹5,515 crore in Q4FY26. The Aditya Birla Group will infuse ₹4,730 crore into the company. Despite this, investor concerns remain over Vodafone’s ability to grow amid high competition and significant debt.
Aditya Birla Fashion doubles down on TMRW, chases scale over profits
TMRW is betting on offline expansion, AI-led operations, and quick commerce to scale profitably, even as skepticism grows around India’s house-of-brands model and ABFRL faces earnings pressure.
Selling at higher levels turns 23,800 into key barrier for Nifty: Analysts
Benchmark Nifty closed lower last week. Analysts anticipate continued range-bound trading for Nifty this week. Trading strategies suggest buying on dips and selling on rallies within the 23,800-23,200 range. Specific stock recommendations include Indus Towers, Samvardhana Motherson International, Aditya Birla Capital, Sun Pharmaceutical Industries, and Arvind Limited. Investors are advised to consider these opportunities.
Prudential Plc to buy 75% Bharti Life stake for ₹3,500 crore, cut ICICI Pru Life holding to 10%
The London-based insurer says the move marks a strategic reset in India, as it secures majority control of Bharti Life Insurance while complying with regulations on ICICI Prudential stake reduction.